stoxline Quote Chart Rank Option Currency Glossary
  
Acutus Medical, Inc. (AFIB)
0.0304  0.002 (8.19%)    05-12 15:45
Open: 0.03
High: 0.0304
Volume: 10,330
  
Pre. Close: 0.0281
Low: 0.03
Market Cap: 1(M)
Technical analysis
2025-05-12 4:45:42 PM
Short term     
Mid term     
Targets 6-month :  0.04 1-year :  0.05
Resists First :  0.03 Second :  0.04
Pivot price 0.03
Supports First :  0.02 Second :  0.02
MAs MA(5) :  0.03 MA(20) :  0.03
MA(100) :  0.04 MA(250) :  0.05
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  17.4 D(3) :  36
RSI RSI(14): 40.3
52-week High :  0.21 Low :  0.02
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AFIB ] has closed above bottom band by 23.0%. Bollinger Bands are 4.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.03 - 0.03 0.03 - 0.03
Low: 0.03 - 0.03 0.03 - 0.03
Close: 0.03 - 0.03 0.03 - 0.03
Company Description

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Headline News

Sat, 10 May 2025
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Looming Class Actions Deadlines - ACCESS Newswire

Thu, 17 Oct 2024
Acutus Medical finalizes settlement with Biotronik, ends agreements - Investing.com

Sat, 11 May 2024
AFIB Stock Price and Chart — OTC:AFIB - TradingView

Wed, 08 Nov 2023
Acutus Medical is laying off more than half of its workers - MassDevice

Tue, 03 Jan 2023
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation at the 2023 AF Symposium - Diagnostic and Interventional Cardiology

Thu, 10 Nov 2022
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo News UK

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
OTC
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 30 (M)
Shares Float 27 (M)
Held by Insiders 9 (%)
Held by Institutions 0 (%)
Shares Short 554 (K)
Shares Short P.Month 985 (K)
Stock Financials
EPS -0.21
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.16
Profit Margin 0 %
Operating Margin -62.3 %
Return on Assets (ttm) -14 %
Return on Equity (ttm) -30 %
Qtrly Rev. Growth 172.3 %
Gross Profit (p.s.) 0
Sales Per Share 0.4
EBITDA (p.s.) -0.51
Qtrly Earnings Growth 0 %
Operating Cash Flow -56 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.16
PEG Ratio 0
Price to Book value -0.2
Price to Sales 0.07
Price to Cash Flow -0.02
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android